John Schiller John Schiller, National Cancer Institute, Bethesda The human papilloma virus vaccine, which is currently being tested in the prevention of cervical cancer, brings together both infectiou
John Schiller
John Schiller, National Cancer Institute, BethesdaThe human papilloma virus vaccine, which is currently being tested in the prevention of cervical cancer, brings together both infectious disease and cancer. Delegates at the ICAAC conference heard an update on both the anti-cancer and the anti-wart activities of the two vaccines: one from Merck and the other from GlaxoSmithKline.
Related Episodes
Which HIV Treatment is Best for Patients with HIV and Hepatitis C?
Juan Berenguer REFERENCE: Abstract V-1385, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JUAN BERENGUER, Hospital Gregorio Marañón, Madrid A ret
Non-Perfect HIV Vaccine Could Still Have Major Benefits
ANTHONY FAUCI, National Institutes of Health, Bethesda REFERENCE: N Engl J Med 2007;356:2073-81 Is there any hope for an HIV vaccine? According to Anthony Fauci, of the National Institutes of Health i
Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety
HOWARD MAYER, Pfizer Global Research, New London CT MARK WAINBERG, McGill University, Montreal Abstract Number: 104aLB, 104bLB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angele